Body Composition Estimated by Bioelectrical Impedance Analysis in Patients with Acute Coronary Syndrome.
Recruiting · NCT06561815 · Observational (researchers observe without assigning treatment) · Lead sponsor: Hospital de Clinicas José de San Martín
View the official record on ClinicalTrials.gov →What this trial is about
This study addresses the critical issue of obesity and its impact on patients with acute coronary syndrome (ACS). While obesity is a known risk factor for cardiovascular diseases, emerging evidence suggests that obese patients with coronary artery disease may have better survival outcomes-a phenomenon known as the \"obesity paradox.\" Our research aims to explore this paradox by examining the body composition of ACS patients using bioimpedance analysis (BIA). We will evaluate parameters such as lean mass, body fat, and fluid volume to assess their relationship with clinical outcomes, including mortality and the incidence of heart and kidney failure. By focusing on body composition rather than just BMI, this study seeks to provide a more accurate understanding of how these factors influence patient outcomes. Conducted at a major hospital in Argentina, the study will contribute valuable insights into the role of body composition in the prognosis of ACS, potentially informing more personalized treatment strategies.
Who can take part
Inclusion criteria
- All patients hospitalized in the Cardiovascular Care Unit with a diagnosis of acute coronary syndrome.
Exclusion criteria
- Decline to participate.
Where it is running
1 location listed.
- Hospital de Clínicas "José de San Martín" - Buenos Aires, Buenos Aires, Argentina